Hayden Luke Bell

3PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

|Mar 19, 2026
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy.

Ran Xu, Gongwei Wu, Siobhan Rice

|Apr 10, 2024
Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia.

Hayden L Bell, Helen J Blair, Samantha J Jepson Gosling

Pageof 1

Frequent Collaborators

2 joint publications

Andrew A Lane

1 joint publications

Daniel Astley

1 joint publications

Anthony V Moorman

1 joint publications

Olaf Heidenreich